Alexion Pharmaceuticals announced that the Company will report its financial results for the second quarter ended June 30, 2019 before the US financial markets open on July 24, 2019.
BOSTON--(BUSINESS WIRE)-- Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the Company will report its financial results for the second quarter ended June 30, 2019 before the US financial markets open on July 24, 2019. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast at 8:00am Eastern Time (ET).
To participate in this conference call, dial 866-762-3111 (USA) or 210-874-7712 (International), conference ID 5564357 shortly before 8:00 a.m. ET. The audio webcast can be accessed on the Investor page of http://ir.alexion.com and an archived version will be available for a limited time following the presentation.
[ALXN-G]
View source version on businesswire.com: https://www.businesswire.com/news/home/20190710005199/en/
Contacts
Investors
Susan Altschuller, Ph.D.
Vice President, Investor Relations
(857) 338-8788
Source: Alexion Pharmaceuticals
View this news release online at:
http://www.businesswire.com/news/home/20190710005199/en
